Literature DB >> 16232331

Features of intestinal T-cell lymphomas in Chinese population without evidence of celiac disease and their close association with Epstein-Barr virus infection.

Wen-yan Zhang1, Gan-di Li, Wei-ping Liu, Qin Ouyang, Xing-chang Ren, Feng-yuan Li, Huan Xu.   

Abstract

BACKGROUND: Intestinal T-cell lymphoma (ITCL) is a heterogeneous lymphoid neoplastic group with variable clinical and pathological features. ITCL in oriental countries is different from enteropathy-type intestinal T-cell lymphoma (ETCL) in relation to celiac disease and Epstein-Barr virus (EBV). The objective of this study was to investigate the clinicopathological features, immunophenotype, expression of cytotoxic molecule (TIA-1), T-cell receptor (TCR)-gamma gene rearrangement, and Epstein-Barr virus (EBV) latent infection in primary ITCL without celiac disease in Chinese.
METHODS: The clinical data of 42 patients were analyzed, and the patients were followed up. Compared with human reactive lymphoid tissues, in situ hybridization for EBER1/2, polymerase chain reaction for TCR-gamma gene rearrangement, and immunohistochemical staining for immunophenotypes, TIA-1 and EBV latent membrane proteins (LMP-1) were investigated. Survival curves of different clinicopathological features, immuno-phenotypes, expression of LMP1, TCR-gamma gene rearrangement and therapy were analyzed.
RESULTS: Three fourths of the patients suffered from ITCL in China were men with a peak age incidence in the 4th decade. Common presenting features included fever and hemotochezia. The prognosis was poor with a median survival of 3.0 months. The lesions were mostly localized in the ileocecum and colon. About 38/42 (90.5%) patients demonstrated pleomorphic medium-sized on large cells. Histological features of celiac disease were rarely seen. All 42 patients with ITCL revealed CD45RO positive. Neoplastic cells partially expressed T-cell differentiated antigens (CD3epsilon, CD4, CD8) and NK cell associated antigen (CD56). The positive frequency of CD3epsilon, CD4, CD8 and CD56 was 28/42 (66.7%), 7/42 (16.7%), 10/42 (23.8%) and 12/42 (28.6%) respectively. Thirty-nine cells (92.9%) expressed TIA-1, but none expressed CD20 and CD68. More than half of the patients (64.3%, 64.3% and 59.5%) revealed TCR-gamma gene rearrangement by three different TCR-gamma primers respectively. EBER1/2 was detected in 41 (97.6%) of the 42 patients. The expression frequency of LMP-1 was 38.1% (16/42).
CONCLUSIONS: Primary ITCL without celiac disease in Chinese is a special highly EBV-associated clinicopathological entity. There are few similarities in patients with celiac disease in western countries. A small proportion of primary ITCLs in Chinese and extranodal NK/T-cell lymphoma of nasal type belong to the same spectrum.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16232331

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  4 in total

Review 1.  Intestinal T-cell lymphomas: a retrospective analysis of 68 cases in China.

Authors:  Zhi-Huan Sun; Hai-Meng Zhou; Guo-Xin Song; Zhong-Xiao Zhou; Liang Bai
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

2.  A case of rapid growing colonic NK/T cell lymphoma complicated by Crohn's disease.

Authors:  Shumei Zheng; Hui Xu; Qin Ouyang; Linyun Xue; Yong Zhang; Dejun Cui
Journal:  Chin J Cancer Res       Date:  2013-02       Impact factor: 5.087

3.  Primary CD56+ NK/T-cell lymphoma of the rectum accompanied with refractory ulcerative colitis.

Authors:  Kazuki Kakimoto; Takuya Inoue; Takashi Nishikawa; Kumi Ishida; Ken Kawakami; Takanori Kuramoto; Yosuke Abe; Eijiro Morita; Naoko Murano; Ken Toshina; Mitsuyuki Murano; Eiji Umegaki; Yutaro Egashira; Junji Okuda; Nobuhiko Tanigawa; Ichiro Hirata; Ken-Ichi Katsu; Kazuhide Higuchi
Journal:  J Gastroenterol       Date:  2008-07-23       Impact factor: 7.527

4.  [Primary colonic extranasal NK/T-cell lymphoma: about a case].

Authors:  Salma Fares; Mouna Lamchahab; Myriem Aniba; Ghizlane Lembarki; Nadia Mousalli; Meriem Regragui; Mehdi Karkouri; Asmaa Quessar
Journal:  Pan Afr Med J       Date:  2017-03-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.